NYSE · BDX

Becton, Dickinson and Co.

$158.92 +$2.56 (+1.64%) 1D After hours
Session Pulse After hours chatter is louder than usual 1 mentions today No new SEC filings since Tue close its sector ranked 5/11 this week Full pulse →

Key Metrics

$43.08B
Market cap
37.86×
P/E · TTM
$21.37B
Revenue · TTM
$1.14B
Net income
EPS · TTM $4.00
Dividend yield 2.8%
Free cash flow $3.14B
Beta · 1Y 0.45
EBITDA · TTM $3.45B
Gross margin

The Story So Far

LAST 6 MONTHS PRIMARY SOURCES ONLY
  • Jul 28
    An insider transaction hit the record.

    Form 4s are events, not verdicts — officers, directors, and 10% owners reporting their own trades. The forms post hours before the media writes them up.

    RECEIPT: SEC FORM 4, TIMESTAMPED
  • Jul 22
    A material event was filed (Form 8-K).

    8-K - BECTON DICKINSON & CO (0000010795) (Filer)

    RECEIPT: SEC FORM 8-K, TIMESTAMPED
  • Jul 16
    Money rotated out of high-beta cohorts market-wide.

    High-beta names lagged the blue-chips by 20.3 points over ten sessions around this date. Stocks in that cohort weren't falling alone — they fell together.

    RECEIPT: ROTATION GAUGE, LIVE
  • Jun 22
    From its Feb 6 high, the share price fell 33%.

    Peak close $210.02 on Feb 6; trough close $140.71 on Jun 22. The drawdown is the fact — the chapters around it are the context.

    RECEIPT: PRICE SERIES, PEAK-TO-TROUGH -33%
  • Feb 10
    The stock moved -17.2% in a single session.

    Sessions this size usually pair with a chapter above or below — a filing, a headline, or the whole cohort moving together.

    RECEIPT: DAILY BAR, Feb 10

The story updates itself as events post · The wolf reports; you decide

Snapshot

Market cap$43.08B
Enterprise value$59.55B
Shares outstanding275.5M
52-wk range$140.11 – $213.08
Avg volume · 20D1.7M
Net cash −$16.47B
Book value / share$84.79
IndustrySurgical & Medical Instruments & Apparatus
ExchangeNYSE
About Becton, Dickinson and Co.
IPO dateSep 25, 1963
Employees72000

Becton Dickinson operates in four business units. Medical essentials (35% of total sales) includes the legacy medical surgical unit, which sells catheters, syringes, and infection prevention products.

Wolf Grade COMING SOON

The wolf is in training. Composite grades vs sector — profitability, health, value, momentum — arrive with the percentile engine. Methodology will be public.

Valuation

P/E37.86
P/S2.02
P/FCF13.71
EV/EBITDA17.24
EV/Sales2.79
Graham №$87.33

Profitability

Gross
Operating 7.7%
Net 5.3%
FCF 14.7%
ROE / ROIC 4.5% · 3.5%

Financial Health

Current ratio0.94
Quick ratio0.55
Debt / equity0.72
Debt / EBITDA 5.00
Net cash −$16.47B
Working capital−$495.00M

Cash Flow · TTM

Operating CF $3.90B
Capex −$759.00M
Free cash flow $3.14B
Buybacks $2.50B
Dividends paid $1.19B
Shareholder yield 8.6%

Piotroski F-Score

5 / 9
Middling fundamentals · 5 of 9 signals passing

Altman Z-Score

Insufficient balance-sheet inputs

Graham Number vs Price

$87.33 vs $158.92
Trades 1.8× above classic defensive value — priced for growth
Fundamentals through 2026-03-31 · computed by TickerWolf from SEC filings